The insider selling, while notable in absolute dollars, is moderate relative to market cap and appears tied to option exercises. No bearish read-through is warranted. Monitor for any upcoming corporate announcements or earnings that could provide context for why key executives executed sales at this juncture.
Price Chart
Executive Summary
A cluster of insider sales at Axsome Therapeutics (AXSM) over the past week totaled ~$20.2M in open-market transactions, led by CEO Herriot Tabuteau ($12.0M) and CFO Nick Pizzie ($7.9M). Director-level sales were minor. At 0.16% of market cap, the selling is modest and likely reflects planned exercises and diversification rather than a bearish signal.
Key Financial Metrics
Key Facts
- CEO sold 49,670 shares at $241.01 for $11.97M on June 9.
- CFO sold 33,000 shares at $240.09 for $7.92M on June 9.
- Three directors sold aggregate ~$304K in small lots.
- Total open-market selling cluster value: ~$20.2M (0.16% of $12.7B market cap).
- All CEO and CFO sales followed derivative exercises (non-cash), consistent with planned transactions.
- No material corporate news or catalyst identified in the filing window.
Financial Impact
~$20.2M in insider open-market sales over 2 days, representing 0.16% of market cap — modest and routine.
Risk Factors
- If future filings reveal a lack of pre-arranged trading plans, the selling could indicate reduced confidence.
- Continued insider selling at current levels might pressure sentiment among retail holders.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-AXSM-1781224472996 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Institutional Cluster | $214.66 $211.12 | ▼ −1.65% | ▲ +0.25% | $176.28 (−17.88%) |
Aug 10, 2026 7w ago | 8-K | $220.89 $207.82 | ▼ −5.92% | ▼ −5.00% | $176.28 (−20.20%) |
Aug 10, 2026 7w ago | Press Release | $220.89 $207.82 | ▼ −5.92% | ▼ −5.00% | $176.28 (−20.20%) |
Jul 15, 2026 11w ago | Press Release | $237.53 $214.66 | ▼ −9.63% | ▼ −11.97% | $176.28 (−25.79%) |
Jul 9, 2026 12w ago | Court Ruling | $248.95 $210.13 | ▼ −15.59% | ▼ −17.84% | $176.28 (−29.19%) |
Jul 7, 2026 12w ago | Press Release | $249.76 $211.04 | ▼ −15.50% | ▼ −16.84% | $176.28 (−29.42%) |
Jul 1, 2026 13w ago | 144 | $244.31 $234.64 | ▼ −3.96% | ▼ −3.54% | $176.28 (−27.85%) |
Jun 15, 2026 15w ago | Press Release | $253.40 $228.28 | ▼ −9.91% | ▼ −9.16% | $176.28 (−30.43%) |
Jun 12, 2026 16w ago | Insider Cluster | $255.17 $233.80 | ▼ −8.37% | ▼ −10.15% | $176.28 (−30.92%) |
Jun 11, 2026 16w ago | 144 | $255.17 $233.80 | ▼ −8.37% | ▼ −10.15% | $176.28 (−30.92%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access